{"action":"buy","ceasedDate":null,"city":"Stockholm","country":"SE","county":"Stockholms län","elfAbbreviation":"AB","elfCode":"XJHM","elfName":"Aktiebolag","isCeased":false,"legalAddress":"L8:01, Karolinska Universitetssjukhuset","legalAddressType":"RegisteredAddress","legalFormLabel":"Aktiebolag","legalName":"AmyloiDia Sweden AB","lei":null,"leiStatus":null,"municipality":"Stockholm","postalCode":"17176","purpose":"Utbildning och implementering av innovativa metoder för diagnosticering och behandling av amyloidsjukdomar såsom Alzheimers, Parkinsons, Creutzfeld-Jakob, Typ 2 diabetes och amyotrofisk lateralskleros (ALS).","registrationDate":"2019-08-27","registrationNumber":"5592162332","registrationNumberFormatted":"559216-2332","registrationNumberNormalized":"5592162332","sniActivities":[{"code":"72101","description":"Bioteknisk forskning och utveckling","rank":1,"section":"N"}],"sniCode":"72101","sniDescription":"Bioteknisk forskning och utveckling","sniRevision":"2025","sniSection":"2025:N","source":"tic-se"}